Myomo (MYO) Interest Expenses (2020)

Name: Myomo (MYO) Interest Expenses (2020) | Business Quant
Creator: Business Quant

Myomo posted quarterly Interest Expenses of $12135.0 for Q3 2020, down 69.68% on a QoQ basis from $40025.0 in Q2 2020.

Myomo (MYO) has 1 years of Interest Expenses data on file, last reported at $12135.0 in Q3 2020.

For the quarter ending Q3 2020, Interest Expenses changed N/A year-over-year to $12135.0; the trailing twelve-month figure through Jun 2021 stood at $12135.0 (down 94.13% YoY), and the FY2020 full-year result was $218803.0, up 92.56% from the prior year.
Interest Expenses for Q3 2020 stood at $12135.0, down from $40025.0 in the prior quarter.
Across five years, Interest Expenses topped out at $166643.0 in Q1 2020 and bottomed at $12135.0 in Q3 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	174.00 Mn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	148.00 Mn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	181.00 Mn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	90.00 Mn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-97.17 Mn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	96.00 Mn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	15.10 Mn
10	Myomo	44.63 Mn	26.23 Mn	-	-

Download Data 🔒